<Disease><Name>FEEDING: AMINO ACID FORMULA [EXTERNAL]</Name><Synonym /><OMIM><Number>---</Number><URL>http://omim.org/entry/---</URL></OMIM><Orphanet><Number /><URL /></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene>Detail information to gene locus by the National Center for Biotechnology Information NCBI:

MAJOR HISTOCOMPATIBILITY COMPLEX
</Gene><ICD /><Summary>artefact that may arise from infant formula preparation - Biotin deficiency in an infant fed with amino acid formula - Increased plasma and urine levels of pyroglutamic acid were found in 4 patients being fed the low-lactose food Nutramigen</Summary><Symptoms><symtomp><id>2233</id><symptom>alopecia</symptom><category>SKIN | SKIN</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3343</id><symptom>skin rash, eczematous or seborrhoic / skin rash</symptom><category>SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>1571</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>3.20</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1703</id><name>3-Methylcrotonylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1710</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>18.00</min><max>33.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>2054</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2058</id><name>3-Methylcrotonylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2059</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>66.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>517</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>43.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>518</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>524</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>49.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>397</id><name>3-Hydroxyisovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>398</id><name>3-Hydroxyisovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>18.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>81</id><name>3-Methylcrotonylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1352</id><name>3-Methylcrotonylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1981</id><name>3-Methylcrotonylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>60.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>72</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>42.00</min><max>115.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>560</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>563</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1168</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>77.00</min><max>133.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1284</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>blood</specimen><value>increased</value><min>14.00</min><max>62.54</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1285</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>serum</specimen><value>increased</value><min>23.80</min><max>106.32</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1977</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>10.20</min><max>32.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>394</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>plasma</specimen><value>increased</value><min>13.00</min><max>161.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>559</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>4</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>596</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>597</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>18.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>599</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>2531</id><title>Biotin deficiency in an infant fed with amino acid formula</title><author>Fujimoto W</author><journal>J Dermatol</journal><year>2005</year><book /><volume>32</volume><number>4</number><pages>2565-261</pages><co_aut>et al.</co_aut></literature><literature><id>1654</id><title>Age-related changes in the proportion of intracranial cerebrospinal fluid space measured using volumetric computerized tomograp</title><author>Wanifuchi H</author><journal>J Neurosurg</journal><year>2002</year><book /><volume>97</volume><number>3</number><pages>607-610</pages><co_aut>Shimizu T, Maruyama T</co_aut></literature><literature><id>1007</id><title>Organic acid analysis</title><author>Hoffmann GF</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guuide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>31-49</pages><co_aut /></literature><literature><id>2534</id><title>Biotin deficiency in an infant fed with amino acid formula and hypoallergenic rice</title><author>Higuchi R</author><journal>Acta Paediatr</journal><year>1996</year><book /><volume>85</volume><number>7</number><pages>872-874</pages><co_aut>et al.</co_aut></literature><literature><id>2533</id><title>Biotin deficiency complicating parenteral alimentation: diagnosis, metabolic repercussions, and treatment</title><author>Mock DM</author><journal>J Pediatr</journal><year>1985</year><book /><volume>106</volume><number>5</number><pages>762-769</pages><co_aut>et al.</co_aut></literature><literature><id>2535</id><title>Increased pyroglutamic acid levels in patients on artificial diets</title><author>Oberholzer VG</author><journal>Clin Chim Acta</journal><year>1975</year><book /><volume>62</volume><number>3</number><pages>299-304</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>